These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14208687)

  • 21. [EFFECTS OF CENTROPHENOXINE ON THE MORPHINE ABSTINENCE SYNDROME].
    LABARRE J
    Therapie; 1964; 19():1055-7. PubMed ID: 14190932
    [No Abstract]   [Full Text] [Related]  

  • 22. [ADMINISTRATION OF CENTROPHENOXINE (LUCIDRYL) IN PSYCHIATRIC PRACTICE].
    TEMKOV I; BOIADZHIEVA M; ZHABLENSKI A
    Suvr Med (Sofiia); 1963; 14():39-45. PubMed ID: 14065745
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary data on results of the application of centrophenoxine (lucidril) in psychiatry].
    MARCJAN K
    Neurol Neurochir Psychiatr Pol; 1962; 12():583-9. PubMed ID: 13932879
    [No Abstract]   [Full Text] [Related]  

  • 24. [Observations on the use of centrophenoxine in hospital and ambulant treatment].
    HOUILLON ; SALLES ; SELIN
    Ann Med Psychol (Paris); 1963 Jun; 2():63-9. PubMed ID: 13955058
    [No Abstract]   [Full Text] [Related]  

  • 25. [LUCIDRIL (A.N.P. 235, CENTROPHENOXINE) --OBSERVATIONS ON THE EFFECT OF THE DRUG].
    ALEKSANDROWICZ J; DZIKOWSKI H
    Neurol Neurochir Psychiatr Pol; 1963; 13():97-101. PubMed ID: 14043242
    [No Abstract]   [Full Text] [Related]  

  • 26. [CENTROPHENOXINE IN PHYSICAL FATIGUE AND PSYCHOPATHOLOGICAL DISORDERS].
    FERNANDEZLABRIOLA RS
    Dia Med; 1963 Nov; 35():1896. PubMed ID: 14106193
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE CONTROL OF CHARCOT'S DISEASE WITH CENTROPHENOXINE (ANP 235, LUCIDRIL). STUDY ON AMYOTROPIC LATERAL SCLEROSIS. XIII].
    SERCL M; KOVARIK J
    Psychiatr Neurol (Basel); 1963; 146():55-63. PubMed ID: 14043294
    [No Abstract]   [Full Text] [Related]  

  • 28. PHARMACOLOGY OF DIMETHYLAMINOETHANOL P-CHLOROPHENOXYACETATE METHIODIDE.
    VIDAL-BERETERVIDE K; MONTI M
    Med Exp Int J Exp Med; 1963; 9():79-83. PubMed ID: 14062109
    [No Abstract]   [Full Text] [Related]  

  • 29. [STUDY OF CENTROPHENOXINE OR ANP-235 AS A FETAL DISTRESS PREVENTION IN OBSTETRICS].
    GONZALEZ J; FRESNADILLORASO A
    Acta Ginecol (Madr); 1965 Apr; 16():197-204. PubMed ID: 14320667
    [No Abstract]   [Full Text] [Related]  

  • 30. [THERAPEUTIC POSSIBILITIES OF PSYCHOACTIVE SUBSTANCES IN THE REGULATION OF MAMMARY SECRETION. PRACTICAL IMPORTANCE OF CENTROPHENOXINE].
    LUISI M
    Minerva Med; 1963 Sep; 54():2578-9. PubMed ID: 14089879
    [No Abstract]   [Full Text] [Related]  

  • 31. [EARLY TREATMENT OF PATIENTS WITH ACUTE AND CHRONIC BRAIN INJURIES WITH HELFERGIN].
    WENZEL E
    Landarzt; 1964 Feb; 40():208-9. PubMed ID: 14339113
    [No Abstract]   [Full Text] [Related]  

  • 32. [IDENTIFICATION AND DETERMINATION OF 2-DIMETHYLAMINOETHYL P-CHLOROPHENOXYACETATE HC1 IN DRAG'EES].
    BERAL H; DUMITRESCU E; GRINTESCU P; CALAFETEANU I
    Farmaco Prat; 1963 Oct; 18():544-8. PubMed ID: 14117136
    [No Abstract]   [Full Text] [Related]  

  • 33. [ATTEMPTED THERAPY WITH THYMOLEPTIC DRUGS (IMIPRAMINE, AMITRIPTYLINE) AND WITH CENTROPHENOXINE IN SOME CASES OF SCHIZOPHRENIA].
    ALEKSANDROWICZ J; DZIKOWSKI H
    Neurol Neurochir Psychiatr Pol; 1963; 13():907-10. PubMed ID: 14122779
    [No Abstract]   [Full Text] [Related]  

  • 34. INCREASED SENSITIVITY TO PENTYLENETETRAZOL AND FLUROTHYL FOLLOWING CORTICAL ABLATIONS IN RATS.
    ADLER MW
    J Pharmacol Exp Ther; 1965 Apr; 148():131-5. PubMed ID: 14279177
    [No Abstract]   [Full Text] [Related]  

  • 35. [Notes on the use of centrophenoxine (ANP 235) in therapeutic psychiatry].
    VIDAL G; VALERY P; VIDAL B
    Ann Med Psychol (Paris); 1961 Jun; 119(2)():145-9. PubMed ID: 13781182
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE EFFECT OF CENTROPHENOXINE (ANP 235, LUCIDRIL) IN CHARCOT'S DISEASE. STUDY ON AMYOTROPHIC LATERAL SCLEROSIS. XIII].
    SERCL M; KOVARIK J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1963; 6():579-85. PubMed ID: 14133061
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of a dimethylaminoethanol ether (ANP 235 or centrophenoxine) on some structures of the central nervous system].
    Bindoni M; Iachello R
    Arch Sci Biol (Bologna); 1966; 50(2):167-80. PubMed ID: 4381352
    [No Abstract]   [Full Text] [Related]  

  • 38. [PHARMACODYNAMIC PROPERTIES OF 2,2-DIPROPYLACETIC ACID. 2D REPORT ON ITS ANTI-EPILEPTIC PROPERTIES].
    LEBRETON S; CARRAZ G; MEUNIER H; BERIEL H
    Therapie; 1964; 19():451-6. PubMed ID: 14138082
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of dimethylaminoethyl p-chlorophenoxyacetate on the life span of male Swiss Webster Albino mice.
    Hochschild R
    Exp Gerontol; 1973 Aug; 8(4):177-83. PubMed ID: 4147092
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the value of dimethylaminoethyl p-chlorophenoxyacetate in the treatment of injuries and diseases of the brain].
    BRENNER H
    Wien Med Wochenschr; 1962 May; 112():347-50. PubMed ID: 13872831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.